Relapsed/Refractory Multiple Myeloma: Role and Safety of Bispecific Antibodies

In this episode, Caitlin Costello, MD, discusses important topics related to relapsed/refractory (R/R) multiple myeloma (MM), including:

3 bispecific antibodies approved for the treatment of R/R MM that target BCMA or GPRC5D

The role of bispecific antibodies in R/R MM

Safety considerations for patients while receiving a bispecific antibody

Emerging data and clinical trials with bispecific antibodies

Key clinical pearls for optimal use of bispecific antibodies

Presenter:

Caitlin Costello, MD

Clinical Professor of Medicine

Director, Multiple Myeloma Program

Division of Blood and Marrow…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.